Rivercell
Rivercell is a BioTech and AI company building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment.
Rivercell has raised €22M across 1 funding round from 4 investors, most recently a Seed round in Oct 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.rivercell.ai ↗
Total raised
€22M
€22,000,000
Funding rounds
1
Investors
4
distinct backers
Active since
2026-10
latest 2026-10
Funding by year
EUR raised per year · 2026 YTDRivercell — funding by year — interactive chart.
Data table
| Rivercell — funding by year | |
|---|---|
| 2026 | €22M |
Signals
High confidenceRaise-next likelihood18
base rate 44% for Seed
- ▼ Raised very recently
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-10-07 | Seed | €22M | Alven Capital,Bpifrance Digital Venture,HCVC,HV Capital | View deal → |
Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData